Skip to Content

Tysabri Prices, Coupons and Patient Assistance Programs

Tysabri (natalizumab) is a member of the selective immunosuppressants drug class and is commonly used for Crohn's Disease - Maintenance and Multiple Sclerosis.

Tysabri Prices

The cost for Tysabri intravenous concentrate (300 mg/15 mL) is around $7,802 for a supply of 15 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Tysabri price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Intravenous Concentrate

300 mg/15 mL Tysabri intravenous concentrate
from $7,801.91 for 15 milliliters
Quantity Per unit Price
15 milliliters $520.13 $7,801.91

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.


Tysabri Coupons and Rebates

Tysabri offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Tysabri Biogen Copay Program: Eligible commercially insured patients will pay $0 Copay with no income requirements and no enrollment time limit; for additional information contact the 800-456-2255.

Applies to:Tysabri
Number of uses:Per prescription until program expires

Tysabri Free Drug Program: Eligible patients in need may qualify for free medication; for additional information contact the program at 800-456-2255.

Applies to:Tysabri
Number of uses:Contact the program

Patient Assistance Programs for Tysabri

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: The Free Drug Program

Elligibility requirements:
  1. Must be uninsured or underinsured
  2. Not disclosed
  3. Relapsing form of MS
  4. The patient must also be residing in the US.
  5. Call for most recent medications as the list is subject to change. Insurance benefits, claims assistance and/or other reimbursement help is offered.

Applicable drugs:

  • Tysabri (natalizumab) Vial; Single-Use

Provider: HealthWell Foundation Copay Program

Elligibility requirements:
  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.

Applicable drugs:

  • Tysabri (natalizumab) Vial; Single-Use

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Tysabri (natalizumab) Vial; Single-Use